Virtus Biotech Clinical Trials ETF (BBC) |
| 48.71 -1.557 (-3.1%) 07-31 15:55 |
| Open: | 48.31 |
| High: | 48.71 |
| Low: | 48.31 |
| Volume: | 14,359 |
| Market Cap: | 46(M) |
| PE Ratio: | 0 |
| Exchange: | New York Stock Exchange Arca |
| Industry: | Asset Management |
| Sector: | Financial Services |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 54.95 |
| Resistance 1: | 52.23 |
| Pivot price: | 50.14 |
| Support 1: | 47.84 |
| Support 2: | 39.80 |
| 52w High: | 54.95 |
| 52w Low: | 20.87 |
This exchange-traded fund (ETF) endeavors to match the capital appreciation and income generation of the LifeSci Biotechnology Clinical Trials Index, disregarding fees and expenses. The underlying index focuses on tracking the financial progress of a carefully chosen group of biotechnology firms engaged in clinical trials. It is important to note that, as of February 27, the fund's official name transitioned from Virtus LifeSci Biotech Clinical Trials ETF to Virtus Biotech Clinical Trials ETF.
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Thu, 30 Jul 2026
BBC ETF Profile: Dividends, Returns (AMEX:BBC) - TradingView
Mon, 27 Jul 2026
Innovative ETF Strategies That Are Paying Off This Summer - MarketBeat
Fri, 17 Jul 2026
Trading the Move, Not the Narrative: (BBC) Edition - Stock Traders Daily
Sun, 05 Jul 2026
Trading the Move, Not the Narrative: (BBC) Edition - Stock Traders Daily
Wed, 01 Jul 2026
June's Top ETFs: Biotech & China Semiconductors Surge - ETF Database
Tue, 30 Jun 2026
Biotech ETF (BBC) Touches a New 52-Week High - Yahoo Finance
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
